Vaccines

Dengue Fever Vaccine Study

Dengue fever is a virus that is carried by mosquitoes, usually in subtropical and tropical climates. Symptoms can range from either being mild or severe. The virus only lasts about a week, but if left untreated it could turn into severe symptoms. We are conducting a phase 2 study of a vaccine for people ages 18-50 years old to test the safety and efficiency of different doses given. It's a one-year-long trial with 8 visits to the office.

*Compensation for time and travel may be available to those who qualify.

Chikungunya Vaccine Study

Chikungunya is a virus that can be spread through mosquito bites similar to other mosquito-spread illnesses like Zika, malaria, dengue, and West Nile Virus. RCR is conducting a study to test the effectiveness of a phase 3 vaccine to prevent Chikungunya in people who are 65 or older. The study will be 7 months long and consists of 5 office visits and 2 phone call appointments.

*Compensation for time and travel may be available to those who qualify.

Lyme Disease Vaccine Study

There currently isn’t a vaccine out there to protect against Lyme disease. RCR is conducting a study testing the safety and efficacy of a phase 3 vaccine to help prevent Lyme disease. This study will last approximately 3 years with 7 visits to our RCR office along with 1 phone call appointment. We are seeking individuals who are 5 years and older to participate in the study.

*Compensation for time and travel may be available to those who qualify.

Flu Vaccine Study

Rochester Clinical Research is now seeking volunteers between the ages of 65 and 85 years old for an influenza vaccine study. The purpose of this research study is to evaluate the safety and effectiveness of an investigational influenza vaccine versus a currently approved influenza vaccine.

*Compensation for time and travel may be available to those who qualify.

CMV Vaccine

Rochester Clinical Research is currently seeking born-female volunteers between the ages of 16 and 40 years old to participate in a CMV vaccine study. The purpose of this study is to find a safe and effective vaccine against Cytomegalovirus.

Chikungunya Vaccine Study

Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the Chikungunya vaccine in healthy adolescents between the ages of 12 and 17 years old. The study will last approximately 6 months with 7 visits to our office. Compensation is available for up to $650 for time and travel, for those who qualify.

*Compensation for time and travel may be available to those who qualify.

COVID booster plus Influenza Vaccine Study

Rochester Clinical Research is now enrolling volunteers between the ages of 18 and 75 years old for an investigational COVID vaccine booster plus flu vaccine study.

Pneumococcal Vaccine Study

Rochester Clinical Research is now seeking volunteers between the ages of 50 and 64 years old for a research study to evaluate the safety and efficacy of an investigational Pneumococcal vaccine.

*Compensation for time and travel may be available to those who qualify.

COVID-19 Vaccine Booster Study Interest List

If you are interested in continuing to advance our protection from COVID-19 and would like to potentially participate in a future booster study designed to protect against specific variants, submit your information to be added to our COVID-19 Vaccine Booster Study interest list.

COVID-19 Vaccine

Rochester Clinical Research is seeking volunteers over the age of 18 for a COVID-19 vaccine study to potentially protect against specific variants of COVID-19.

COVID booster plus Pneumococcal Vaccine Study

Rochester Clinical Research is seeking volunteers 50 years old and up for a study to evaluate the safety and effectiveness of a combination pneumococcal and COVID vaccine.

RSV Vaccine Study

If you are interested in helping find a vaccine to prevent RSV, and want to join a future RSV trial at RCR join our interest list!